Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694366,Abfw8,Abdominal fat weight QTL 8,6.38,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),18,46640675,83828827,Rat,n/a,region,qtl 1000,1598826,Anxrr20,Anxiety related response QTL 20,3.04,,body movement coordination trait (VT:0005424),number of rearing movements in an experimental apparatus (CMO:0001752),18,41432971,83828827,Rat,n/a,region,qtl 1000,2313399,Anxrr28,Anxiety related response QTL 28,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),6,100671796,132340886,Rat,n/a,region,qtl 1000,738034,Anxrr5,Anxiety related response QTL 5,5.9,,exploratory behavior trait (VT:0010471),percentage of entries into a discrete space in an experimental apparatus (CMO:0000961),6,84130881,129130881,Rat,n/a,region,qtl 1000,1331799,Bp211,Blood pressure QTL 211,3.66407,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),6,72202632,130919985,Rat,n/a,region,qtl 1000,1331725,Bp212,Blood pressure QTL 212,3.52475,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),6,93701310,128713626,Rat,n/a,region,qtl 1000,1331797,Bp213,Blood pressure QTL 213,3.291,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),6,104085867,128713626,Rat,n/a,region,qtl 1000,1331741,Bp232,Blood pressure QTL 232,3.59112,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),18,21372893,83213037,Rat,n/a,region,qtl 1000,1331733,Bp233,Blood pressure QTL 233,3.97196,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),18,24796977,79788953,Rat,n/a,region,qtl 1000,2301969,Bp324,Blood pressure QTL 324,4.05,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),18,59712417,76477814,Rat,n/a,region,qtl 1000,6903353,Bp353,Blood pressure QTL 353,2.8,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),18,59796478,83828827,Rat,n/a,region,qtl 1000,6903356,Bp354,Blood pressure QTL 354,4.6,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),18,59796478,83828827,Rat,n/a,region,qtl 1000,61384,Bp48,Blood pressure QTL 48,19.4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),18,60622311,77209844,Rat,n/a,region,qtl 1000,70185,BpQTLcluster15,Blood pressure QTL cluster 15,4.61,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),18,59712417,76477814,Rat,n/a,region,qtl 1000,70185,BpQTLcluster15,Blood pressure QTL cluster 15,4.61,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),18,59712417,76477814,Rat,n/a,region,qtl 1000,70185,BpQTLcluster15,Blood pressure QTL cluster 15,4.61,,arterial blood pressure trait (VT:2000000),absolute change in mean arterial blood pressure (CMO:0000533),18,59712417,76477814,Rat,n/a,region,qtl 1000,70185,BpQTLcluster15,Blood pressure QTL cluster 15,4.61,,arterial blood pressure trait (VT:2000000),absolute change in systolic blood pressure (CMO:0000607),18,59712417,76477814,Rat,n/a,region,qtl 1000,1578661,Bss20,Bone structure and strength QTL 20,3.7,,femur morphology trait (VT:0000559),femoral neck cross-sectional area (CMO:0001697),18,11791518,83218561,Rat,n/a,region,qtl 1000,1578667,Bss21,Bone structure and strength QTL 21,3.5,,femur morphology trait (VT:0000559),femoral neck cortical cross-sectional area (CMO:0001702),18,11791518,83218561,Rat,n/a,region,qtl 1000,631518,Bw11,Body weight QTL 11,2.8,,body mass (VT:0001259),body weight (CMO:0000012),18,35870723,80870723,Rat,n/a,region,qtl 1000,6893683,Bw110,Body weight QTL 110,2.7,0.002,body mass (VT:0001259),body weight (CMO:0000012),18,43345022,83828827,Rat,n/a,region,qtl 1000,8694432,Bw165,Body weight QTL 165,3.81,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),18,46640675,83828827,Rat,n/a,region,qtl 1000,2303571,Bw92,Body weight QTL 92,3,,body mass (VT:0001259),body weight (CMO:0000012),18,48520044,83828827,Rat,n/a,region,qtl 1000,1298072,Cia26,Collagen induced arthritis QTL 26,3.6,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),18,54709769,83828827,Rat,n/a,region,qtl 1000,70172,Eae15,Experimental allergic encephalomyelitis QTL 15,,0.001,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046),18,76477814,77209844,Rat,n/a,region,qtl 1000,9589041,Epfw12,Epididymal fat weight QTL 12,17.08,0.001,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),18,46640675,83828827,Rat,n/a,region,qtl 1000,1300076,Glom8,Glomerulus QTL 8,7,0.000000009,kidney glomerulus morphology trait (VT:0005325),count of superficial glomeruli directly contacting the kidney surface (CMO:0001001),6,86894788,131894788,Rat,n/a,region,qtl 1000,2303584,Gluco55,Glucose level QTL 55,2,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),18,48520044,83828827,Rat,n/a,region,qtl 1000,10054138,Gmadr3,Adrenal mass QTL 3,3.68,0.00045,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),6,85140138,130140138,Rat,n/a,region,qtl 1000,738008,Hcar14,Hepatocarcinoma resistance QTL 14,4.3,,liver integrity trait (VT:0010547),liver nonremodeling tumorous lesion number (CMO:0001462),18,51464733,83218561,Rat,n/a,region,qtl 1000,631675,Iddm15,Insulin dependent diabetes mellitus QTL 15,,,urine glucose amount (VT:0001758),percentage of study population developing diabetes mellitus during a period of time (CMO:0001114),18,60622311,77209844,Rat,n/a,region,qtl 1000,1298087,Iddm18,Insulin dependent diabetes mellitus QTL 18,,0.0001,urine glucose amount (VT:0001758),percentage of study population developing diabetes mellitus during a period of time (CMO:0001114),6,116506292,130245370,Rat,n/a,region,qtl 1000,61367,Iddm4,Insulin dependent diabetes mellitus QTL 4,2.33,0.0074,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),18,38192455,83192455,Rat,n/a,region,qtl 1000,71111,Iddm8,Insulin dependent diabetes mellitus QTL 8,1.9,0.002,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),6,105156861,140994061,Rat,n/a,region,qtl 1000,724542,Kidm2,Kidney mass QTL 2,2.6,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),18,59172115,83828827,Rat,n/a,region,qtl 1000,1600373,Mamtr6,Mammary tumor resistance QTL 6,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),18,19278901,83218561,Rat,n/a,region,qtl 1000,2303120,Mamtr8,Mammary tumor resistance QTL 8,,0.001,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),18,31359408,83218561,Rat,n/a,region,qtl 1000,4145118,Mcs26,Mammary carcinoma susceptibility QTL 26,,0.0001,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),6,106752656,132339866,Rat,n/a,region,qtl 1000,634333,Pia19,Pristane induced arthritis QTL 19,3.4,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),18,73997140,79532029,Rat,n/a,region,qtl 1000,737976,Pia24,Pristane induced arthritis QTL 24,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),6,112636280,140994061,Rat,n/a,region,qtl 1000,61414,Pia3,Pristane induced arthritis QTL 3,4.5,,joint integrity trait (VT:0010548),post-insult time to onset of experimental arthritis (CMO:0001450),6,94968928,137848904,Rat,n/a,region,qtl 1000,1581550,Pur8,Proteinuria QTL 8,,,urine total protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),6,72227641,130729205,Rat,n/a,region,qtl 1000,12801411,Schws8,Schwannoma susceptibility QTL 8,,,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),6,94968928,139968928,Rat,n/a,region,qtl 1000,631274,Sprol1,Serum protein level QTL 1,5.3,,blood total protein amount (VT:0005567),serum total protein level (CMO:0000661),18,31393320,77209694,Rat,n/a,region,qtl 1000,1358355,Srcrt4,Stress Responsive Cort QTL 4,6.39,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),6,100364669,140994061,Rat,n/a,region,qtl 1000,10054123,Srcrt6,Stress Responsive Cort QTL 6,2.5,0.0043,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),6,85140138,130140138,Rat,n/a,region,qtl 1000,724513,Uae14,Urinary albumin excretion QTL 14,6.5,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,85311061,133478515,Rat,n/a,region,qtl 1000,731173,Uae22,Urinary albumin excretion QTL 22,10.1,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,65531555,140994061,Rat,n/a,region,qtl 1000,1581563,Uae33,Urinary albumin excretion QTL 33,,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,72227641,130729205,Rat,n/a,region,qtl 1000,2290393,Uae37,Urinary albumin excretion QTL 37,,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,65531555,140994061,Rat,n/a,region,qtl 1000,724536,Uae7,Urinary albumin excretion QTL 7,3.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),6,72202632,130729475,Rat,n/a,region,qtl 1000,2303624,Vencon5,Ventilatory control QTL 5,4.45,,respiration trait (VT:0001943),minute ventilation (CMO:0000132),6,88047916,133047916,Rat,n/a,region,qtl 1000,8552796,Vie3,Viral induced encephalitis QTL 3,2.6,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),6,96833997,140994061,Rat,n/a,region,qtl